Dobutrex

Therapeutic procedure, Coronary Disease, Heart Attack + 3 more

Treatment

2 FDA approvals

20 Active Studies for Dobutrex

What is Dobutrex

Dobutamine

The Generic name of this drug

Treatment Summary

Dobutamine is a drug used to increase the strength of heart contractions, making it useful for treating heart conditions such as after a heart attack or open heart surgery. It works by stimulating the beta-1 receptors in the heart without causing an increase in heart rate or narrowing of the blood vessels.

Dobutamine Hydrochloride in Dextrose

is the brand name

image of different drug pills on a surface

Dobutrex Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Dobutamine Hydrochloride in Dextrose

Dobutamine

1993

22

Approved as Treatment by the FDA

Dobutamine, otherwise called Dobutamine Hydrochloride in Dextrose, is approved by the FDA for 2 uses like Cardiac Decompensation and Heart Failure .

Cardiac Decompensation

Helps manage Cardiac Decompensation

Heart Failure

Helps manage Cardiac Decompensation

Effectiveness

How Dobutrex Affects Patients

Dobutamine is a drug that strengthens the heart and increases its ability to pump blood. It works by activating the beta-1 adrenergic receptors in the heart, but has only small effects on other types of receptors. Unlike dopamine, it does not cause the body to produce more norepinephrine.

How Dobutrex works in the body

Dobutamine helps the heart pump more blood by stimulating the beta-1 receptors in the heart. This increases the amount of blood the heart pumps out, resulting in a greater cardiac output.

When to interrupt dosage

The quantity of Dobutrex is contingent upon the identified disorder, including Heart Attack, Cardiac Surgical Procedures (D006348) and Coronary Artery Disease (CAD). The amount of dosage is contingent upon the technique of delivery (e.g. Intravenous or Liquid - Intravenous) specified in the following table.

Condition

Dosage

Administration

Heart Failure

, 12.5 mg/mL, 4.0 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 2.5 mg/mL, 25.0 mg/mL

, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Liquid, Liquid - Intravenous, Solution - Intravenous, Solution, Injection, Injection - Intravenous, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous

Coronary Disease

, 12.5 mg/mL, 4.0 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 2.5 mg/mL, 25.0 mg/mL

, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Liquid, Liquid - Intravenous, Solution - Intravenous, Solution, Injection, Injection - Intravenous, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous

Heart Attack

, 12.5 mg/mL, 4.0 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 2.5 mg/mL, 25.0 mg/mL

, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Liquid, Liquid - Intravenous, Solution - Intravenous, Solution, Injection, Injection - Intravenous, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous

Cardiac Surgical Procedures (D006348)

, 12.5 mg/mL, 4.0 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 2.5 mg/mL, 25.0 mg/mL

, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Liquid, Liquid - Intravenous, Solution - Intravenous, Solution, Injection, Injection - Intravenous, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous

Therapeutic procedure

, 12.5 mg/mL, 4.0 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 2.5 mg/mL, 25.0 mg/mL

, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Liquid, Liquid - Intravenous, Solution - Intravenous, Solution, Injection, Injection - Intravenous, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous

Stress Echocardiography (SE)

, 12.5 mg/mL, 4.0 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 2.5 mg/mL, 25.0 mg/mL

, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Liquid, Liquid - Intravenous, Solution - Intravenous, Solution, Injection, Injection - Intravenous, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous

Warnings

Dobutrex has one contraindication, and should not be utilized if any of the conditions in the following table are present.

Dobutrex Contraindications

Condition

Risk Level

Notes

Cardiomyopathy, Hypertrophic

Do Not Combine

There are 20 known major drug interactions with Dobutrex.

Common Dobutrex Drug Interactions

Drug Name

Risk Level

Description

Iobenguane

Major

Dobutamine can cause a decrease in the absorption of Iobenguane resulting in a reduced serum concentration and potentially a decrease in efficacy.

1-benzylimidazole

Minor

The risk or severity of hypertension can be increased when Dobutamine is combined with 1-benzylimidazole.

2,5-Dimethoxy-4-ethylamphetamine

Minor

The risk or severity of hypertension can be increased when Dobutamine is combined with 2,5-Dimethoxy-4-ethylamphetamine.

2,5-Dimethoxy-4-ethylthioamphetamine

Minor

The risk or severity of hypertension can be increased when Dobutamine is combined with 2,5-Dimethoxy-4-ethylthioamphetamine.

4-Bromo-2,5-dimethoxyamphetamine

Minor

The risk or severity of hypertension can be increased when Dobutamine is combined with 4-Bromo-2,5-dimethoxyamphetamine.

image of a doctor in a lab doing drug, clinical research

Dobutrex Novel Uses: Which Conditions Have a Clinical Trial Featuring Dobutrex?

63 active studies are presently investigating the potential of Dobutrex to effectuate Therapeutic procedure, Cardiac Decompensation and Myocardial Infarction.

Condition

Clinical Trials

Trial Phases

Heart Failure

0 Actively Recruiting

Heart Attack

23 Actively Recruiting

Not Applicable, Phase 1, Phase 4, Phase 2, Early Phase 1, Phase 3

Stress Echocardiography (SE)

0 Actively Recruiting

Coronary Disease

1 Actively Recruiting

Not Applicable

Therapeutic procedure

0 Actively Recruiting

Cardiac Surgical Procedures (D006348)

0 Actively Recruiting

Dobutrex Reviews: What are patients saying about Dobutrex?

2.7

Patient Review

3/16/2009

Dobutrex for Failure of the Heart to Maintain Adequate Circulation

1

Patient Review

10/5/2010

Dobutrex for Failure of the Heart to Maintain Adequate Circulation

We had to convince the medical staff multiple times to stop giving this medication to our son while he was in the ICU. Every time they administered it, his vitals would drop and everything would go haywire for a couple hours.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about dobutrex

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is dobutrex used for?

"Dobutamine is a drug that is used to stimulate the heart muscle and improve blood flow. It is typically used in cases where the heart muscle has weakened and other heart medications have not been successful."

Answered by AI

Does dobutrex increase heart rate?

"Dobutamine primarily increases stroke volume and cardiac output in healthy animals due to its inotropic effects. There is also a small increase in heart rate, which is a minor contribution to the increase in cardiac output."

Answered by AI

Does dobutrex increase blood pressure?

"Dobutamine increases heart rate and blood pressure, especially systolic pressure. In clinical studies, 10% of patients had an increase in heart rate of 30 beats per minute or more, and 7.5% had an increase in systolic pressure of 50 mm Hg or more."

Answered by AI

What type of drug is dobutrex?

"Dobutrex is a synthetic catecholamine that helps improve the heart's pumping ability by strengthening the heart muscle. It also helps improve blood flow and relieve symptoms associated with heart failure."

Answered by AI

Clinical Trials for Dobutrex

Image of St Boniface Hospital in Winnipeg, Canada.

Remote Home Monitoring for Heart Attack

18+
All Sexes
Winnipeg, Canada

Heart attacks are one of the top causes of death in Canada, with over 2,100 cases treated each year in Manitoba. Even though hospital care has improved, the period after going home is still risky. Many patients feel anxious and unsure about their recovery, and without enough support, they often end up back in the emergency department (ED). This is an even bigger challenge for people in rural areas, where getting follow-up care can be much harder. Filling these gaps is important to help patients get better and to reduce stress on the healthcare system. In a previous study, the investigators found that extra support made a big difference: only 8% of participants using a digital health tool returned to the ED within 30 days, compared to 22% of participants without it. Now, the investigators want to expand this study across Manitoba to see if digital health tools can help more people recover safely at home. The investigators will compare two types of follow-up care: education only versus education with extra support (like symptom tracking and virtual appointments). The investigators will look at how this affects hospital visits, mental well-being, and healthcare costs. The goal is to create a better support system for people after a heart attack, leading to healthier recoveries, less strain on hospitals, and better care for Manitobans - no matter where they live.

Waitlist Available
Has No Placebo

St Boniface Hospital

Have you considered Dobutrex clinical trials?

We made a collection of clinical trials featuring Dobutrex, we think they might fit your search criteria.
Go to Trials
Image of Abcentra Investigational Site in Los Angeles, United States.

Orticumab for Heart Attack

18+
All Sexes
Los Angeles, CA

The goal of this clinical trial is to determine the clinical effect of orticumab treatment on inflammation in study participants with prior myocardial infarction who have elevated coronary inflammation based on CCTA. The main question it aims to answer is: Clinical effects of orticumab treatment on inflammation of the coronary artery parameters measured with CCTA Researchers will compare the effects with placebo group after 6 months of treatment Participants will Keep the planned study visit appointments Provide complete information about medical and medical history Speak to the study doctor before changing any of non-study treatments, including starting new medications, receiving any vaccinations, or setting out to join any other clinical studies

Phase 2
Recruiting

Abcentra Investigational Site (+6 Sites)

Abcentra

Image of The Ohio State University Wexner Medical Center in Columbus, United States.

Health Coaching for Cardiovascular Disease

18+
All Sexes
Columbus, OH

For patients discharged with a diagnosis of cardiovascular disease coronary artery disease resulting in myocardial infarction and/or congestive heart failure, this study will evaluate if the addition of 12 virtual health coaching sessions over the course of 16 weeks will improve physiological, psychological, and social health outcomes, prove acceptable and satisfactory for these patients with CVD, decrease CVD-related questions and concerns sent to the provider via MyChart, and reduce hospital readmission rates over a 90-day period as compared to patients discharged with the same diagnosis who receive standard post-discharge care. The study will also evaluate the perceptions of physician and advanced practice providers related to the health coach as part of the interprofessional team and the amount of time spent addressing CVD-related patient questions and concerns via MyChart messages.

Waitlist Available
Has No Placebo

The Ohio State University Wexner Medical Center

Beth Steinberg, PhD, RN

Have you considered Dobutrex clinical trials?

We made a collection of clinical trials featuring Dobutrex, we think they might fit your search criteria.
Go to Trials
Image of Rancho Los Amigos National Rehabilitation Center in Downey, United States.

BP REACH Intervention for High Blood Pressure

18+
All Sexes
Downey, CA

BP-REACH is a study of a team-based (pharmacist and health coach) program for lowering blood pressure for people with a prior stroke or heart attack in the Los Angeles Department of Health Services healthcare system. The goal of this clinical trial is to test if this team based program is better at helping people reduce their blood pressure than usual care for people with prior heart attack or stroke. The main questions it aims to answer are: * Do people in the REACH BP program have lower blood pressure at 12 months compared to those getting usual care? * Do people in the REACH BP program have better Life's Essential 8 scores and patient experience compared to those getting usual care?

Recruiting
Has No Placebo

Rancho Los Amigos National Rehabilitation Center (+3 Sites)

Alejandra Casillas, MD

Have you considered Dobutrex clinical trials?

We made a collection of clinical trials featuring Dobutrex, we think they might fit your search criteria.
Go to Trials